Entellus Medical, Inc.
(NASDAQ : ENTL)

( )
ENTL PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories
0.00%60.200.8%$499.84m
MDTMedtronic PLC
0.00%83.360.6%$456.10m
ISRGIntuitive Surgical, Inc.
0.00%415.982.5%$383.99m
ALGNAlign Technology, Inc.
0.00%251.506.3%$370.91m
TMOThermo Fisher Scientific Inc.
0.00%210.611.0%$344.36m
BDXBecton, Dickinson and Company
0.00%222.901.1%$343.88m
SYKStryker Corporation
0.00%159.861.3%$248.32m
BAXBaxter International Inc.
0.00%66.331.7%$241.80m
BSXBoston Scientific Corporation
0.00%27.211.1%$235.28m
EWEdwards Lifesciences Corporation
0.00%133.791.2%$189.58m
ZBHZimmer Biomet Holdings, Inc.
0.00%120.491.7%$182.67m
XRAYDENTSPLY International Inc.
0.00%58.433.0%$140.89m
WATWaters Corporation
0.00%206.143.3%$129.01m
VARVarian Medical Systems, Inc.
0.00%121.269.1%$126.75m
ABMDABIOMED, Inc.
0.00%267.743.3%$126.43m

Company Profile

Entellus Medical, Inc. is a medical technology company focused on the design, development and commercialization of products for the treatment of chronic sinusitis. Its XprESS family of products is used by ear, nose and throat, physicians to open narrowed or obstructed sinus drainage pathways using balloon sinus dilation to treat patients with symptomatic inflammation of the nasal sinuses. Entellus Medical was founded by Thomas V. Ressemann and Peter Keith in April 2006 and is headquartered in Plymouth, MN.